Structural requirements for the development of potent N-methyl-D-aspartic acid (NMDA) receptor antagonists.

Suppr

超能文献

作者信息

Bigge C F

机构信息

Department of Chemistry, Parke-Davis Pharmaceutical Research, Warner-Lambert Co., Ann Arbor, MI 48105.

出版信息

Biochem Pharmacol. 1993 Apr 22;45(8):1547-61. doi: 10.1016/0006-2952(93)90294-7.

DOI:10.1016/0006-2952(93)90294-7

PMID:7683469

Abstract

摘要

相似文献

Structural requirements for the development of potent N-methyl-D-aspartic acid (NMDA) receptor antagonists.

Biochem Pharmacol. 1993 Apr 22;45(8):1547-61. doi: 10.1016/0006-2952(93)90294-7.

N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.N-甲基-D-天冬氨酸受体：谷氨酸拮抗剂、甘氨酸拮抗剂及通道阻滞剂结合所需的不同亚基

Mol Pharmacol. 1994 Mar;45(3):540-5.

Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.烷基和烷氧基取代的1,4 - 二氢喹喔啉 - 2,3 - 二酮的构效关系：NMDA受体甘氨酸位点的强效且具有全身活性的拮抗剂

J Med Chem. 1997 Feb 28;40(5):730-8. doi: 10.1021/jm960654b.

Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors.喹喔啉类和犬尿氨酸类作为N-甲基-D-天冬氨酸受体甘氨酸位点拮抗剂的选择性。

Mol Pharmacol. 1989 Sep;36(3):430-6.

The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential.

J Med Chem. 1994 Nov 25;37(24):4053-67. doi: 10.1021/jm00050a001.

The glycine site of the NMDA receptor--five years on.NMDA受体的甘氨酸位点——五年之后

Trends Pharmacol Sci. 1993 Jan;14(1):20-5. doi: 10.1016/0165-6147(93)90108-v.

NMDA receptor antagonists and glycine site NMDA antagonists.NMDA受体拮抗剂和甘氨酸位点NMDA拮抗剂。

Curr Med Res Opin. 2002;18 Suppl 2:s27-31. doi: 10.1185/030079902125000705.

Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.N-（2,5-二取代苯基）-N'-（3-取代苯基）-N'-甲基胍作为N-甲基-D-天冬氨酸受体离子通道阻滞剂的合成与药理评价

J Med Chem. 1997 Dec 19;40(26):4281-9. doi: 10.1021/jm970459c.

Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor.

J Pharmacol Exp Ther. 1995 Dec;275(3):1267-73.

4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones: excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity.4,5-二氢-1,2,4-三唑并[1,5-a]喹喔啉-4-酮：兼具甘氨酸/N-甲基-D-天冬氨酸受体亲和力和α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体亲和力的兴奋性氨基酸拮抗剂

J Med Chem. 1999 Jul 1;42(13):2478-84. doi: 10.1021/jm981102r.

引用本文的文献

Pretreatment with group I metabotropic glutamate receptors antagonists attenuates lethality induced by acute cocaine overdose and expression of sensitization to hyperlocomotor effect of cocaine in mice.用 I 组代谢型谷氨酸受体拮抗剂预处理可减轻急性可卡因过量中毒引起的致死性，并减轻可卡因引起的过度运动效应的敏化表达。

Neurotox Res. 2011 Jan;19(1):23-30. doi: 10.1007/s12640-009-9136-8. Epub 2009 Nov 21.

Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid.一种新型的优先作用于NR2C/NR2D的N-甲基-D-天冬氨酸受体拮抗剂的构效分析：1-(菲-2-羰基)哌嗪-2,3-二羧酸

Br J Pharmacol. 2004 Feb;141(3):508-16. doi: 10.1038/sj.bjp.0705644. Epub 2004 Jan 12.

Neurotoxic potential of three structural analogs of beta-N-oxalyl-alpha,beta-diaminopropanoic acid (beta-ODAP).β-N-草酰-α,β-二氨基丙酸（β-ODAP）三种结构类似物的神经毒性潜力。

Neurochem Res. 1999 Jun;24(6):791-7. doi: 10.1023/a:1020791815848.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验